Mirion Technologies Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics:

Total Revenue: $266.8 million, up 20% year-over-year; organic revenue growth was 1%.

Adjusted EBITDA: $65.3 million, a 27.5% increase from the previous year, with margins expanding by 150 basis points.

Adjusted EPS: $0.12 per share; adjusted EPS calculation now includes stock-based compensation.

Free Cash Flow: Generated $49 million in adjusted free cash flow for the quarter.

Backlog: Over $1.1 billion, a 40% increase year-over-year, with legacy backlog growing by 17%.

2Strategic Updates and Business Highlights:

Continued momentum in the nuclear power sector, supported by regulatory improvements and new agreements (e.g., Walmart's nuclear power deal).

Successful integration of acquisitions (Paragon and Certrec) contributing to revenue and backlog growth.

Advancements in artificial intelligence (AI) strategy aimed at enhancing product development, operational efficiencies, and customer solutions.

Notable orders in July, including a large European installed base order and a U.S. Department of Energy order, contributing to a strong pipeline.

3Forward Guidance and Outlook:

Full-Year Guidance: Maintained with expectations for significant financial performance acceleration in the second half of 2026.

Q3 Guidance: Anticipated organic revenue growth in the high single digits; adjusted EBITDA margins expected to expand.

Nuclear Power Segment: Projected double-digit organic revenue growth for the full year, driven by installed base and SMR orders.

4Bad News, Challenges, or Points of Concern:

A cancellation of an $18 million Chinese new build order due to geopolitical tensions, although it is not expected to impact full-year guidance significantly.

Organic revenue growth in the medical segment declined by 1%, attributed to delayed hardware demand and tough year-over-year comparisons.

Concerns about the impact of short-cycle power supply on nuclear projects, though management remains confident in the long-term demand for nuclear power.

5Notable Q&A Insights:

Management expressed confidence in their large opportunity pipeline, indicating a strong probability of winning contracts.

The M&A pipeline remains robust, with a focus on complementary assets.

The disconnect between strong order growth in nuclear power and flat revenue was explained as a timing issue, with expectations for a revenue ramp in the second half.

Management addressed concerns regarding backlog quality, asserting that the recent debooking from China is an isolated incident and does not indicate broader risks.

The company is actively monitoring government dynamics, particularly related to the Department of Energy, which could influence future orders. Overall, Mirion Technologies demonstrated solid financial performance in Q2 2026, with a strong outlook driven by nuclear power momentum and strategic initiatives in AI and acquisitions, despite facing some challenges in the medical segment and a recent order cancellation.